Universal Peace Federation (UPF) Holds Global Seminar on the Theme “Opportunity and Hope at a Time of Global Crisis: Interdependence, Mutual Prosperity, and Universal Values.”
In an attempt to spread hope and optimism during the coronavirus pandemic which has infected more than 27 million people and killed over 189,000 globally, UPF, an NGO in general consultative status with the Economic and Social Council of the United Nations will convene its first virtual International Leadership Conference (ILC) on Sept. 11-13, 2020.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200910005456/en/
Former Secretary-General of the United Nations, Mr. Ban Ki-moon said at the recent virtual summit “Rally of Hope”, Aug. 9, 2020, he believed that “UPF will become a cornerstone to build lasting peace around the world.” (Photo: Business Wire)
The ILC will host concurrent webinars in three, time-zone friendly clusters: the Americas, Asia Pacific, and the combined continents of Europe, Africa, and the Middle East.
“This year has seen dramatic disruptions, not only due to the COVID-19 pandemic but in geopolitics, the world economy, the media, religion and all levels of society,” said Universal Peace Federation Chairman Dr. Thomas G. Walsh.
“When the world’s leaders and citizens gather and listen to each other,” he added, “it’s easy to envision how our friendships can grow, and how we can live as one global family.”
Former Secretary-General of the United Nations, Mr. Ban Ki-moon said at the recent virtual summit “Rally of Hope”, Aug. 9, 2020, he believed that “UPF will become a cornerstone to build lasting peace around the world.”
In addition to addressing major issues of the day, the conference will commemorate the 15-year anniversary of the Universal Peace Federation and the centenary of UPF’s Co-Founder, Rev. Dr. Sun Myung Moon (1920-2012).
Featured speakers in the Europe, Africa and Middle-East Peace-Dialogue will include former heads of state such as Goodluck Jonathan from Nigeria or H.E Marie-Louise Coleiro Preca from Malta, or Dr. Werner Fasslabend, former minister of defense, Austria, religious leaders with a large following such as Prophet Radebe from South Africa or Cheikh Soufi Bilal Diallo from Mali, and business leaders such as the philanthropist Joseph Busha from Zimbabwe.
The September 11-13 program will highlight the work of UPF’s seven Associations: International Summit Council for Peace (ISCP), International Association of Parliamentarians for Peace (IAPP), Interreligious Association for Peace and Development (IAPD), International Media Association for Peace (IMAP), International Association of Academicians for Peace (IAAP), International Association for Peace and Economic Development (IAED) and International Association of First Ladies for Peace (IAFLP).
Please register for the ILC sessions here: http://www.ilc-2020.org. You will then receive by email an invitation including all the links for each session as well as a brief description of each session. In addition to English, translations will be available in Arabic, French, Portuguese, Spanish and Russian. Attendance is free.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200910005456/en/
Contact information
Peter Zoehrer
Media Relations, UPF Europe & Middle East
media@europe.upf.org
Websites: UPF.ORG & EUME.UPF.ORG
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ProAmpac Acquires International Paper’s Bag Converting Operations17.10.2025 17:09:00 EEST | Press release
ProAmpac, a global leader in flexible packaging and material science, has acquired the bag converting operations of International Paper (“IP”), a global leader in sustainable packaging. The acquisition expands ProAmpac’s converting capabilities, further advancing the company’s Fiberization of Packaging® strategy and enhancing its ability to deliver customized bag solutions for the grocery, convenience store, and quick-service restaurant markets. “Global demand for reliable, recyclable paper packaging continues to grow rapidly amid evolving consumer expectations and market trends redefining recyclability,” stated Greg Tucker, ProAmpac founder, vice chairman, and chief executive officer. “ProAmpac’s acquisition of IP’s bag operation supports our Fiberization of Packaging initiatives, helping us better serve customers by extending our expertise in material science to the US west coast with additional capabilities and redundancies,” continued Tucker. “IP’s bag business is strong, being bui
Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT17.10.2025 17:00:00 EEST | Press release
Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., for the treatment of patients with tenosynovial giant cell tumor (TGCT). This latest analysis showed that, with a median follow-up of 14.3 months, the objective response rate (ORR) for people treated with pimicotinib from the beginning of the study increased considerably to 76.2% (95% CI: 63.8, 86.0) by blinded independent review committee (BICR) per RECIST v1.1, from 54% at Week 25. The study also showed continued clinically meaningful improvements in key secondary endpoints related to patient outcomes such as pain and function. The safety profile was consistent with previously reported data. The results are being presented today in the Sarcoma mini-oral session at the European Society for Medical
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week17.10.2025 16:04:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein therapeutic and dual antagonist of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines. Pove has demonstrated best-in-class potential in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) and has pipeline-in-a-product potential across a range of B cell-mediated diseases. Pove is the only BAFF+APRIL inhibitor in pivotal trials for multiple kidney diseases. Next Steps for Pove Development In IgAN Following the announcement that the Food and Drug Administration (FDA) granted Breakthrough Therapy Designation (BTD) to pove for the treatment of IgAN, FDA recently granted a rolling review of the Biologics License Application (BLA) for pove for this indication. Vertex expects to submit the first module to FDA for potential accelerated approval before t
Qualcomm Announces Quarterly Cash Dividend17.10.2025 16:00:00 EEST | Press release
Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.89 per common share, payable on December 18, 2025, to stockholders of record at the close of business on December 4, 2025. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built with our leading-edge AI, high-performance, low-power computing, and unrivaled connectivity. Our Snapdragon® platforms power extraordinary consumer experiences, and our Qualcomm Dragonwing™ products empower businesses and industries to scale to new heights. Together with our ecosystem partners, we enable next-generation digital transformation to enrich lives, improve businesses, and advance societies. At Qualcomm, we are engineering human progress. Qualcomm Incorporated includes our licensing
Illumynt Reports Q3 2025 Business Update17.10.2025 15:39:00 EEST | Press release
Q3 2025 was a busy quarter once again for us here at illumynt. In addition to naming a new CEO, we executed on a number of initiatives that are propelling our organization forward. Revenue for the quarter exceeded $30 million- keeping us on track for our 2025 plan. More importantly we executed three different large-scale data center decommission projects with almost no material ending up as scrap. All of the AI-focused enterprise equipment and components recovered from the decommissions were resold at top market value. We head into Q4 with high expectations and our eyes wide open. We’re celebrating the 20-year anniversary of our facility in Hong Kong and looking to add another location in the region to help us process inbound AI data center equipment. Stay tuned for updates. There will be more on the way. View source version on businesswire.com: https://www.businesswire.com/news/home/20251017446548/en/
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom